Aion Therapeutic Inc
CNSX:AION
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Aion Therapeutic Inc
Free Cash Flow
Aion Therapeutic Inc
Free Cash Flow Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
Aion Therapeutic Inc
CNSX:AION
|
Free Cash Flow
-CA$40k
|
CAGR 3-Years
62%
|
CAGR 5-Years
34%
|
CAGR 10-Years
17%
|
|
|
High Tide Inc
XTSX:HITI
|
Free Cash Flow
CA$18.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
24%
|
CAGR 10-Years
N/A
|
|
|
Canopy Growth Corp
TSX:WEED
|
Free Cash Flow
-CA$86.7m
|
CAGR 3-Years
46%
|
CAGR 5-Years
36%
|
CAGR 10-Years
-11%
|
|
|
OrganiGram Holdings Inc
TSX:OGI
|
Free Cash Flow
-CA$36.9m
|
CAGR 3-Years
21%
|
CAGR 5-Years
14%
|
CAGR 10-Years
-20%
|
|
|
Sundial Growers Inc
NASDAQ:SNDL
|
Free Cash Flow
CA$58.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Cronos Group Inc
TSX:CRON
|
Free Cash Flow
-$190k
|
CAGR 3-Years
87%
|
CAGR 5-Years
75%
|
CAGR 10-Years
22%
|
|
Aion Therapeutic Inc
Glance View
Aion Therapeutic, Inc. is an emerging international pharmaceutical company, which focuses on the healing powers of medical cannabis and medicinal mushroom compounds. The company is headquartered in Toronto, Ontario. The company went IPO on 2019-02-21. The firm is focused on the development of combinatorial pharmaceuticals, nutraceuticals and cosmeceuticals utilizing compounds from cannabis (cannabinoids), psychedelic mushrooms (psilocybin), fungi (edible mushroom), natural psychedelic formulations (Ayahuasca) and other medicinal plants for discovery.
See Also
What is Aion Therapeutic Inc's Free Cash Flow?
Free Cash Flow
-40k
CAD
Based on the financial report for Apr 30, 2023, Aion Therapeutic Inc's Free Cash Flow amounts to -40k CAD.
What is Aion Therapeutic Inc's Free Cash Flow growth rate?
Free Cash Flow CAGR 10Y
17%
Over the last year, the Free Cash Flow growth was 97%. The average annual Free Cash Flow growth rates for Aion Therapeutic Inc have been 62% over the past three years , 34% over the past five years , and 17% over the past ten years .
